IP Library › Assignment 042129/0369
Patent Assignment
Reel/Frame 042129/0369

Assignment of Assignor's Interest

Recorded: 2017-04-24 Pages: 2
Assignor
ZHANG, FENG
Executed: 2012-10-06
Assignee
FORMULATION TECHNOLOGIES, LLC DBA PHARMAFORM
11501 DOMAIN DRIVE, SUITE 130, AUSTIN, TEXAS, 78758
Covered Property (1)
Methods for Treatment of Attention Deficit Hyperactivity Disorder
Patent: 9,889,095 →
Application: 15/470,705 →
Publication: US 2017/0196817
Related Assignments (6)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest Apr 24, 2017
From: HIGHLAND THERAPEUTICS, INC.
To: IRONSHORE PHARMACEUTICALS & DEVELOPMENT, INC.
Reel/Frame 042129/0651 →
Assignment of Assignor's Interest Apr 24, 2017
From: LICKRISH, DAVID
To: IRONSHORE PHARMACEUTICALS & DEVELOPMENT, INC.
Reel/Frame 042129/0775 →
Assignment of Assignor's Interest Apr 24, 2017
From: FORMULATION TECHNOLOGIES LLC DBA PHARMAFORM
To: HIGHLAND THERAPEUTICS INC.
Reel/Frame 042322/0572 →
Patent Security Agreement Sep 3, 2024
From: IRONSHORE PHARMACEUTICALS & DEVELOPMENT, INC.
To: BIOPHARMA CREDIT PLC
Reel/Frame 068826/0711 →
Security Interest Dec 23, 2025
From: COLLEGIUM PHARMACEUTICAL, INC.; BIODELIVERY SCIENCES INTERNATIONAL, INC.; IRONSHORE PHARMACEUTICALS & DEVELOPMENT, INC.
To: TRUIST BANK, A NORTH CAROLINA CHARTERED BANK
Reel/Frame 073302/0334 →
Release of Security Interest Dec 23, 2025
From: BIOPHARMA CREDIT PLC
To: IRONSHORE PHARMACEUTICALS & DEVELOPMENT, INC.
Reel/Frame 073308/0416 →